Active: Apparent treatment-resistant hypertension Clear all

GWAS 2023-12-13

Whole genome sequence analysis of apparent treatment resistant hypertension status in participants from the Trans-Omics for Precision Medicine program.

Armstrong ND, Srinivasasainagendra V et al.

Front Genet

Introduction: Apparent treatment-resistant hypertension (aTRH) is characterized by the use of four o...

Apparent treatment-resistant hypertension

7129

Participants

N/A

Studies

Details PubMed

GWAS 2022-11-30

A genome-wide association study identifies a novel association between SDC3 and apparent treatment-resistant hypertension.

Xiao X, Li R et al.

BMC Med

Compared with patients who require fewer antihypertensive agents, those with apparent treatment-resi...

Apparent treatment-resistant hypertension

1358

Participants

N/A

Studies

Details PubMed

GWAS 2019-09-23

Genome wide association study of apparent treatment resistant hypertension in the CHARGE consortium: The CHARGE Pharmacogenetics Working Group.

Irvin MR, Sitlani CM et al.

Am J Hypertens

Only a handful of genetic discovery efforts in apparent treatment-resistant hypertension (aTRH) have...

Resistant hypertension

Replicated

17849

Participants

N/A

Studies

Details PubMed

Title

Author

Journal

Disease/Trait

Date

Actions

Whole genome sequence analysis of apparent treatment resistant hypertension status in participants from the Trans-Omics for Precision Medicine program.

Armstrong ND, Srinivasasainagendra V et al.

Front Genet

Apparent treatment-resistant hypertension

2023-12-13

A genome-wide association study identifies a novel association between SDC3 and apparent treatment-resistant hypertension.

Xiao X, Li R et al.

BMC Med

Apparent treatment-resistant hypertension

2022-11-30

Genome wide association study of apparent treatment resistant hypertension in the CHARGE consortium: The CHARGE Pharmacogenetics Working Group.

Irvin MR, Sitlani CM et al.

Am J Hypertens

Resistant hypertension

2019-09-23